CSL welcomes the Government’s plan to further develop onshore mRNA vaccine manufacturing capability.
While mRNA vaccine technology has been explored by researchers for many years, the COVID-19 pandemic has accelerated this technology from what was a promising science to a viable technology platform that can be produced at industrial scale.
CSL’s vaccine business – Seqirus – is one of the world’s leading influenza vaccine companies with Australia’s only onshore influenza manufacturing facility. For several years, Seqirus has been researching next-generation mRNA – self- amplifying mRNA – for influenza and pre-clinical results appear promising, with human clinical trials due to commence next year.
CSL subsidiary Seqirus operates Australia’s only onshore influenza vaccine manufacturing facility.
Related Quotes
Advertisement
The company said COVID-19 has accelerated the technology from a promising science to a viable technology platform that can be produced at industrial scale.
Seqirus senior vice president for research and development Russell Basser said research for next-generation mRNA, known as self-amplifying mRNA, for influenza had seen promising pre-clinical results. Human clinical trials are due to commence next year.
“CSL has a 100-year track record as a proven pandemic partner to Australia,” Dr Basser said.
“Our skilled workforce, deep expertise in biotech manufacturing, global supply network and unwavering promise in responding to the nation’s biosecurity needs is at the heart of who we are – both from our history and still today.
Health by Jackie Sinnerton
Premium Content The University of Queensland s abandoned COVID vaccine could have been the world s best weapon in the fight against the deadly virus, with a new study revealing it was effective after just one jab and could be stored at fridge temperature. The findings are in stark contrast to the Pfizer and AstraZeneca vaccines, which are being relied on to protect the nation and require two doses each - a huge logistical challenge which is further complicated by Pfizer needing to be stored at -70C. UQ s crack vaccine team is now working behind the scenes to move the vaccine technology forward after the research, released today, showed if it was reworked and problems ironed out it could still be a boon in the fight against COVID-19 and future global novel viruses.
Abandoned Qld vaccine effective after one shot gympietimes.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gympietimes.com.au Daily Mail and Mail on Sunday newspapers.